Fidelity Investments
LMAT icon

Fidelity Investments’s LeMaitre Vascular LMAT Stock Holding History

Fidelity Investments’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$618K Sell
6,444
-619
-9% -$63.5K ﹤0.01% 3200
2026
Q1 		$771K Buy
7,063
+1,018
+17% +$97K ﹤0.01% 2962
2025
Q4 		$490K Sell
6,045
-52
-0.9% -$4.48K ﹤0.01% 3095
2025
Q3 		$534K Buy
6,097
+335
+6% +$29.9K ﹤0.01% 3007
2025
Q2 		$479K Sell
5,762
-650
-10% -$54.3K ﹤0.01% 2972
2025
Q1 		$538K Sell
6,412
-5,838
-48% -$543K ﹤0.01% 2876
2024
Q4 		$1.13M Buy
12,250
+1,682
+16% +$162K ﹤0.01% 2628
2024
Q3 		$982K Buy
10,568
+8,114
+331% +$703K ﹤0.01% 2605
2024
Q2 		$202K Buy
2,454
+996
+68% +$73.2K ﹤0.01% 3021
2024
Q1 		$96.8K Buy
1,458
+286
+24% +$17.6K ﹤0.01% 3301
2023
Q4 		$66.5K Sell
1,172
-161
-12% -$8.43K ﹤0.01% 3393
2023
Q3 		$72.6K Buy
1,333
+112
+9% +$6.64K ﹤0.01% 3214
2023
Q2 		$82.1K Buy
1,221
+588
+93% +$35.9K ﹤0.01% 3239
2023
Q1 		$32.6K Buy
633
+334
+112% +$16.2K ﹤0.01% 3629
2022
Q4 		$13.8K Sell
299
-576
-66% -$27K ﹤0.01% 3907
2022
Q3 		$44K Sell
875
-7,420
-89% -$371K ﹤0.01% 3540
2022
Q2 		$378K Sell
8,295
-6,153
-43% -$275K ﹤0.01% 2932
2022
Q1 		$672K Buy
14,448
+14,417
+46,506% +$645K ﹤0.01% 2897
2021
Q4 		$2K Sell
31
-13
-30% -$672 ﹤0.01% 4022
2021
Q3 		$2K Buy
44
+1
+2% +$56 ﹤0.01% 4021
2021
Q2 		$3K Buy
+43
New +$2.28K ﹤0.01% 3842
2021
Q1 		– Sell
-1
Closed – – 4307
2020
Q4 		$0 Buy
+1
New +$36 ﹤0.01% 4107
2020
Q1 		– Sell
-36
Closed -$1K – 4009
2019
Q4 		$1K Buy
+36
New +$1.24K ﹤0.01% 3661
2019
Q2 		– Sell
-1
Closed – – 3999
2019
Q1 		$0 Sell
1
-129
-99% -$3.44K ﹤0.01% 3959
2018
Q4 		$3K Sell
130
-48
-27% -$1.31K ﹤0.01% 3276
2018
Q3 		$7K Buy
+178
New +$6.41K ﹤0.01% 3178

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments's LMAT Position: Q2 2026 in Review

Fidelity Investments reduced its LeMaitre Vascular (LMAT) stake by 8.8% in Q2 2026, selling an estimated $63.5K and leaving 6,444 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Fidelity Investments first reported a position in LMAT in Q3 2018 and has held it in 26 quarters since. The position peaked at $1.13M in Q4 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Fidelity Investments held 6,444 shares of LeMaitre Vascular worth $618K as of Q2 2026.
  • Fidelity Investments sold 619 LeMaitre Vascular shares in Q2 2026, an estimated $63.5K.
  • LeMaitre Vascular made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3200 holding.
  • Fidelity Investments first reported a position in LeMaitre Vascular in Q3 2018 and has held it in 26 quarters since.
  • Fidelity Investments's LeMaitre Vascular position peaked at $1.13M in Q4 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.